Nova Eye Medical (OTCMKTS:ELXMF – Get Rating) is one of 121 publicly-traded companies in the “Medical Devices” industry, but how does it compare to its rivals? We will compare Nova Eye Medical to similar companies based on the strength of its analyst recommendations, institutional ownership, dividends, valuation, earnings, profitability and risk.
Profitability
This table compares Nova Eye Medical and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nova Eye Medical | N/A | N/A | N/A |
| Nova Eye Medical Competitors | -113.56% | -36.49% | -14.98% |
Insider & Institutional Ownership
12.4% of Nova Eye Medical shares are held by institutional investors. Comparatively, 29.8% of shares of all “Medical Devices” companies are held by institutional investors. 27.8% of shares of all “Medical Devices” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Valuation & Earnings
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Nova Eye Medical | N/A | N/A | 13.70 |
| Nova Eye Medical Competitors | $523.09 million | $20.26 million | 141.49 |
Nova Eye Medical’s rivals have higher revenue and earnings than Nova Eye Medical. Nova Eye Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Analyst Recommendations
This is a summary of recent recommendations for Nova Eye Medical and its rivals, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nova Eye Medical | 0 | 0 | 0 | 0 | N/A |
| Nova Eye Medical Competitors | 179 | 768 | 778 | 40 | 2.38 |
As a group, “Medical Devices” companies have a potential upside of 53.31%. Given Nova Eye Medical’s rivals higher probable upside, analysts plainly believe Nova Eye Medical has less favorable growth aspects than its rivals.
Summary
Nova Eye Medical rivals beat Nova Eye Medical on 5 of the 8 factors compared.
Nova Eye Medical Company Profile
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.
Receive News & Ratings for Nova Eye Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova Eye Medical and related companies with MarketBeat.com's FREE daily email newsletter.
